Partnering

Sanofi Pasteur, Sanofi’s vaccines global business unit, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have formed a multi-year research and development (R&D) pact and licensing deal to…

Gilead Sciences and Hookipa Biotech, a Vienna, Austria-headquartered biopharmaceutical company developing immunotherapies for cancer and infectious diseases, have formed a research and license pact worth up to $410 million that…

Adocia, a Lyon, France-headquartered biopharmaceutical company developing new formulations for approved therapeutic proteins, has expanded its pact with Tonghua Dongbao, a Tonghua, China-based pharmaceutical product provider, for Tonghua Dongbao to…

Amgen and the University of Texas MD Anderson Cancer Center have formed two multi-year collaborations to accelerate development of a variety of Amgen’s early-stage oncology therapies for treating patients with…

Celgene and Evotec, a Hamburg, Germany-based drug-discovery and development company, have entered into a long-term drug discovery and development partnership to identify new therapeutics in oncology. Evotec’s preclinical discovery and…

Vectalys, a Toulouse, France-based biotechnology company specializing in lentiviral manufacturing services, and Auriga Partners, a venture-capital firm, have partnered to form FlashCell, a new gene-therapy company specialized in developing RNA…

Medigene, a Martinsried, Germany-based biotechnology company focused on personalized T-cell-based immunotherapies, has expanded its strategic alliance with bluebird bio, a Cambridge, Massachusetts-based clinical-stage gene therapy company, for research and development…

Melinta Therapeutics, a New Haven, Connecticut-based biopharmaceutical company developing antibiotics, has partnered with CARB-X, a Boston, Massachusetts-based partnership organization focused on early-development antibacterial research and development, to support developing Melinta’s…

AstraZeneca has partnered with Procella Therapeutics and Smartwise, wholly owned subsidiaries of SWIB Holdings, a Stockholm, Sweden-based biotech and medical-device investment company, to develop ways of regenerating parts of the…

Merck & Co. and Moderna Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on messenger RNA (mRNA) therapeutics, have expanded their 2016 collaboration to develop and commercialize mRNA cancer vaccines to…